A trans-cultural comparison of the organisation of care at headache centres world-wide

Cephalalgia

Volumn 31, Issue 3, 2011, Pages 316-330

  Bhola, Ria ^a   Goadsby, Peter J ^b  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

headache; Headache centres; migraine; transcultural

Indexed keywords

ACETYLSALICYLIC ACID; BOTULINUM TOXIN; CAFFEINE; CAFFEINE PLUS ERGOTAMINE TARTRATE; DIHYDROERGOTAMINE; INDOMETACIN; LIDOCAINE; PARACETAMOL; TOPIRAMATE; TRIPTAN DERIVATIVE;

ARTICLE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HEADACHE; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HEALTH CARE PRACTICE; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH CENTER; HEALTH SERVICE; HUMAN; LENGTH OF STAY; MIGRAINE; NERVE BLOCK; NERVE STIMULATION; OUTCOME ASSESSMENT; TEAMWORK; TERTIARY HEALTH CARE; TRANSCULTURAL CARE; TRANSFORMED MIGRAINE;

HEADACHE; HOSPITALS, SPECIAL; HUMANS; NEUROLOGY;

EID: 79953215308     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102410380756     Document Type: Article

References (66)

1. Olesen J., Tfelt-Hansen P., Ramadan N., Goadsby PJ and Welch KMA. The Headaches. Philadelphia, PA: Lippincott, Williams & Wilkins, 2005.
2. Headache Classification Committee of The International Headache Society. The International Classification of Headache Disorders (2nd edition). Cephalalgia 2004 ; 24 (Suppl 1). 1-160.
3. Menken M., Munsat TL and Toole JF The global burden of disease study - implications for neurology. Arch Neurol 2000 ; 57: 418-420. (Pubitemid 30140537)
4. Goadsby PJ Pathophysiology of cluster headache: a trigeminal autonomic cephalalgia. Lancet Neurol 2002 ; 1: 37-43.
5. Sjaastad O. and Bakketeig LS Cluster headache prevalence. Vaga study of headache epidemiology. Cephalalgia 2003 ; 23: 528-533. (Pubitemid 37114974)
6. Berg J. and Stovner LJ Cost of migraine and other headaches in Europe. Eur J Neurol 2005 ; 12 (Suppl 1). 59-62. (Pubitemid 40755606)
7. Dueland AN, Leira R., Burke TA, Hillyer EV and Bolge S. The impact of migraine on work, family, and leisure among young women - a multinational study. Curr Med Res Opin 2004 ; 20: 1595-1604. (Pubitemid 39457547)
8. Bhola R., Kaube H. and Goadsby PJ Patient satisfaction with hospital management in a referral setting in the UK. Cephalalgia 2004 ; 24: 1097.
9. Jauslin P., Goadsby PJ and Lance JW The hospital management of severe migrainous headache. Headache 1991 ; 31: 658-660.
10. Raskin NH Repetitive intravenous dihydroergotamine as therapy for intractable migraine. Neurology 1986 ; 36: 995-997. (Pubitemid 16098249)
11. Bhola R., Kaube H. and Goadsby PJ Role of a clinical nurse specialist (CNS) in an in-patient headache service in the UK. Cephalalgia 2004 ; 24: 1096-1097.
12. Afridi SK, Shields KG, Bhola R. and Goadsby PJ Greater occipital nerve injection in primary headache syndromes- prolonged effects from a single injection. Pain 2006 ; 122: 126-129.
13. Goadsby PJ, Boes C. and Sudlow CLM. Low CSF volume (pressure) headache. Pract Neurol 2002 ; 2: 192-197.
14. Goadsby PJ and Lipton RB A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic features, including new cases. Brain 1997 ; 120: 193-209. (Pubitemid 27081270)
15. Cohen AS, Burns B. and Goadsby PJ High flow oxygen for treatment of cluster headache. A randomized trial. JAMA 2009 ; 302: 2451-2457.
16. Cittadini E. and Goadsby PJ Hemicrania continua: a clinical study of 39 patients with diagnostic implications. Brain 2010 ; 133: 1973-1986.
17. Nagy AJ, Gandhi S., Bhola R. and Goadsby PJ A review of inpatient intravenous dihydroergotamine (DHE) for the treatment of headache. Cephalalgia 2007 ; 27: 710.
18. Goadsby PJ and Gundlach AL Localization of [3H]-dihydroergotamine binding sites in the cat central nervous system: relevance to migraine. Ann Neurol 1991 ; 29: 91-94.
19. Weatherall MW, Kaube H. and Goadsby PJ Intravenous aspirin (lysine acetylsalicylate) is effective and well tolerated in the in-patient management of headache. Neurology 2010 ; In press.
20. Andreou AP, Summ O., Charbit AR, Romero Reyes M. and Goadsby PJ Animal models of headache - from bedside to bench and back to beside. Expt Rev Neurother 2010 ; 10: 389-411.
21. Bergerot A., Holland PR, Akerman S., Bartsch T., Ahn AH, MaassenVanDenBrink A., et al. Animal models of migraine. Looking at the component parts of a complex disorder. Eur J Neurosci 2006 ; 24: 1517-1534. (Pubitemid 44429881)
22. Silberstein SD, Neto W., Schmitt J. and Jacobs D. Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol 2004 ; 61: 490-495. (Pubitemid 38923736)
23. Silberstein SD, Schulman EA and Hopkins MM Repetitive intravenous DHE in the treatment of refractory headache. Headache 1990 ; 30: 334-339. (Pubitemid 20361182)
24. Silberstein SD, Lipton RB, Solomon S. and Mathew NT Classification of daily or near-daily headaches: proposed revisions to the IHS criteria. Headache 1994 ; 34: 1-7. (Pubitemid 24038967)
25. Olesen J., Bousser MG, Diener HC, Dodick D., First M., Goadsby P., et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006 ; 26: 742-746.
26. Oshinsky ML and Luo J. Neurochemistry of trigeminal activation in an animal model of migraine. Headache 2006 ; 46 (Suppl 1). S39 - S44.
27. Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N., Mathew N., et al. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache 2007 ; 47: 170-180.
28. Saper JR, Mathew NT, Loder EW, DeGryse R. and VanDenburgh AM A double-blind, randomised, placebo-controlled exploratory study comparing injection sites with low doses of botulinum toxin type A in the prevention of episodic migraine. J Neurol 2005 ; 252 (Suppl 2): II - 58.
29. Saper J., Dodick DW, Silberstein S., McCarville S., Sun M. and Goadsby PJ Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study. Cephalalgia 2010 ; 40 ; In press.
30. Cutrer FM, Goadsby PJ, Ferrari MD, Lipton RB, Dodick DW, McCrory D., et al. Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project). Clin Ther 2004 ; 26: 1533-1545. (Pubitemid 39572163)
31. Black DF, Swanson JW, Eross EJ and Cutrer FM Secondary SUNCT due to intraorbital, metastatic bronchial carcinoid. Cephalalgia 2005 ; 25: 633-635. (Pubitemid 41026031)
32. Loder E., Harrington MG, Cutrer M., Sandor P. and De Vries B. Selected confirmed, probable and exploratory migraine biomarkers. Headache 2006 ; 46: 1108-1127. (Pubitemid 43992581)
33. Moskowitz MA and Cutrer FM Sumatriptan: a receptor-targeted treatment for migraine. Annu Rev Med 1993 ; 44: 145-154.
34. Diener H-C., Dodick DW, Aurora SK, Turkel CC, DeGryse RE, Lipton RB, et al. Onabotulinum toxin A for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia 2010 ; 40 ; In press.
35. Dodick D., Brandes J., Elkind A., Mathew N. and Rodichok L. Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study. CNS Drugs 2005 ; 19: 125-136. (Pubitemid 40321764)
36. Diener HC, Kurth T. and Dodick D. Patent foramen ovale and migraine. Curr Pain Headache Rep 2007 ; 11: 236-240. (Pubitemid 46851254)
37. Dodick DW, Sandrini G. and Williams P. Use of the sustained pain-free plus no adverse events endpoint in clinical trials of triptans in acute migraine. CNS Drugs 2007 ; 21: 73-82. (Pubitemid 46072351)
38. Schwedt TJ, Dodick DW, Trentman TL and Zimmerman RS Response to occipital nerve block is not useful in predicting efficacy of occipital nerve stimulation. Cephalalgia 2007 ; 27: 271-274. (Pubitemid 46354117)
39. Trentman TL, Zimmerman RS, Seth N., Hentz JG and Dodick DW Stimulation ranges, usage ranges, and paresthesia mapping during occipital nerve stimulation. Neuromodulation 2008 ; 11: 56-61.
40. Olesen J., Friberg L., Skyhoj-Olsen T., Iversen HK, Lassen NA, Andersen AR, et al. Timing and topography of cerebral blood flow, aura, and headache during migraine attacks. Ann Neurol 1990 ; 28: 791-798.
41. Lauritzen M. Pathophysiology of the migraine aura. The spreading depression theory. Brain 1994 ; 117: 199-210. (Pubitemid 24103394)
42. Iversen HK, Olesen J. and Tfelt-Hansen P. Intravenous nitroglycerin as an experimental headache model. Basic characteristics. Pain 1989 ; 38: 17-24. (Pubitemid 19184833)
43. Lassen LH, Ashina M., Christiansen I., Ulrich V. and Olesen J. Nitric oxide synthesis inhibition in migraine. Lancet 1997 ; 349: 401-402. (Pubitemid 27077677)
44. Headache Classification Committee of The International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988 ; 8 (Suppl 7): 1-96.
45. Reuter U., Bolay H., Jansen-Olesen I., Chiarugi A., Sanchez del Rio M., Letourneau R., et al. Delayed inflammation in rat meninges: implications for migraine pathophysiology. Brain 2001 ; 124: 2490-2502. (Pubitemid 33134937)
46. Sams-Nielsen A., Orskov C. and Jansen-Olesen I. Pharmacological evidence for CGRP uptake into perivascular capsaicin sensitive nerve terminals. Br J Pharmacol 2001 ; 132: 1145-1153. (Pubitemid 32238920)
47. Suwattanasophon C., Phansuwan-Pujito P. and Srikiatkhachorn A. 5-HT(1B/1D) serotonin receptor agonist attenuates nitroglycerin-evoked nitric oxide synthase expression in trigeminal pathway. Cephalalgia 2003 ; 23: 825-832. (Pubitemid 37255425)
48. Srikiatkhachorn A., Suwattanasophon C., Ruangpattanatawee U. and Phansuwan-Pujito P. 5-HT2A receptor activation and nitric oxide synthesis: a possible mechanism determining migraine attacks. Headache 2002 ; 42: 566-574.
49. Lambert GA, Davis JB, Appleby JM, Chizh BA, Hoskin KL and Zagami AS The effects of the TRPV1 receptor antagonist SB-705498 on trigeminovascular sensitisation and neurotransmission. Naunyn Schmiedebergs Arch Pharmacol 2009 ; 380: 311-325.
50. Lambert GA, Hoskin KL and Zagami AS Cortico-NRM influences on trigeminal neuronal sensation. Cephalalgia 2008 ; 28: 640-652. (Pubitemid 351614941)
51. Zagami AS, Edvinsson L., Hoskin KL and Goadsby PJ Stimulation of the superior sagittal sinus causes extracranial release of PACAP. Cephalalgia 1995 ; 15 (Suppl 14): 109.
52. Zagami AS, Gordon V. and Lambert GA Medial thalamic neurones respond to electrical stimulation of cranial vessels. J Clin Neurosci 1996 ; 3: 412-413.
53. Zagami AS and Lambert GA Craniovascular application of capsaicin activates nociceptive thalamic neurons in the cat. Neurosci Lett 1991 ; 121: 187-190.
54. Knight YE, Classey JD, Lasalandra MP, Akerman S., Kowacs F., Hoskin KL, et al. Patterns of fos expression in the rostral medulla and caudal pons evoked by noxious craniovascular stimulation and periaqueductal gray stimulation in the cat. Brain Res 2005 ; 1045: 1-11. (Pubitemid 40725214)
55. Kowacs F., Williamson DJ and Goadsby PJ Neurogenic vasodilation of dural blood vessels is not mediated by cholinergic transmission in the anaesthetised rat. Eur J Pharmacol 2004 ; 493: 133-137. (Pubitemid 38746942)
56. Kowacs F., Giffin NJ, Putzki N., Goadsby PJ and Kaube H. Nociceptive specific blink reflex and glyceryl trinitrate infusion in healthy volunteers. Eur J Neurol 2003 ; 10: 295-300.
57. Schwedt TJ and Shapiro RE Funding of research on headache disorders by the National Institutes of Health. Headache 2009 ; 49: 162-169.
58. World Health Organization. Core Health Indicators World Health Statistics. 2007
59. World Health Organization. The World Health Report. Working together for health. 2006
60. California HealthCare Foundation. Health Care Costs 101. Katherine B. Wilson, 2007
61. U.S. Census Bureau. Income, Poverty, and Health Insurance Coverage in the United States: 2006 census. 2007 ; 60-233
62. Department of Health. 2005
63. Ministry of the Interior of Health. Health Care in Denmark. 2002
64. World Health Organization. Statistical Information System: Core Health Indicators, Thailand. [accessed June 2009].
65. World Health Organization. WHO Statistical Information System. Australia.
66. Health in Brazil. Wikipedia [accessed February 2009].